Upfront autologous hematopoietic stem cell transplantation in patients with high-risk stage III to IV Hodgkin lymphoma: a multicenter retrospective cohort study.
CONCLUSION: The use of ASCT as a first-line consolidation treatment could improve outcome of patients with advanced-stage high risk HL whose interim PET/CT was positive.
PMID: 31081725 [PubMed - in process]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research
More News: Cancer & Oncology | Chemotherapy | CT Scan | Hematology | Lymphoma | PET Scan | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplants